AstraZeneca Faces Patent Challenge For Best-Selling Drug

Law360, New York (September 28, 2005, 12:00 AM EDT) -- Israeli drug maker Teva Pharmaceutical Industries Ltd. is seeking to produce a generic version of the schizophrenia drug Seroquel, which garnered drug originator AstraZeneca $2 billion in worldwide sales last year.

Teva has filed an Abbreviated New Drug Application with the Food and Drug Administration (ANDA) with the U.S. Food and Drug Administration to make a 25 mg version of Seroquel.

Seroquel is the Anglo-Swedish company’s best selling drug, with sales accounting for nearly 10% of AstraZeneca’s revenues. In the U.S. alone, the drug generated $1.5...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.